This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Berberis aristata
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
Berberine activates AMPK (the metabolic master switch), reducing blood sugar, improving insulin sensitivity, and lowering LDL cholesterol; clinical evidence rivals metformin.
Berberine activates AMPK (the metabolic master switch), reducing blood sugar, improving insulin sensitivity, and lowering LDL cholesterol; clinical evidence rivals metformin. Key active compounds include Berberine, Berbamine, Oxyacanthine.
Berberine, along with Berbamine and Oxyacanthine, are the primary bioactive compounds in Berberine Metabolic. These compounds improves insulin sensitivity and glucose metabolism, supports cardiovascular function through lipid metabolism and vasodilation.
Type 2 diabetes management (clinical evidence rivals metformin)
Supported by clinical evidence; more large-scale trials would strengthen findings
Cholesterol and triglyceride reduction
Supported by clinical evidence; more large-scale trials would strengthen findings
AMPK activation and weight management
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Blood sugar management in Asian traditional medicine
Based on traditional use; clinical evidence limited
Liver and digestive disorders
Based on traditional use; clinical evidence limited
Antimicrobial use
Based on traditional use; clinical evidence limited
Found an error or have a correction for Berberine Metabolic?
Report an Issue →